Smith & Nephew plc logo
Smith & Nephew plc SNN
$ 31.16 0.74%

Annual report 2025
added 04-18-2026

report update icon

Smith & Nephew plc Gross Profit 2011-2026 | SNN

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Smith & Nephew plc

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.19 B 4.05 B 3.82 B 3.68 B 3.67 B 3.16 B 3.8 B 3.61 B 3.52 B 3.4 B 3.49 B 3.46 B 3.25 B 3.07 B 3.13 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.19 B 3.07 B 3.55 B

Gross Profit of other stocks in the Medical devices industry

Issuer Gross Profit Price % 24h Market Cap Country
AdaptHealth Corp. AdaptHealth Corp.
AHCO
89.3 M $ 13.17 0.46 % $ 1.78 B usaUSA
BIOLASE BIOLASE
BIOL
16.7 M - -13.19 % $ 166 K usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
67.9 M - - $ 1.77 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
443 K - 3.58 % $ 2.21 M usaUSA
Eargo Eargo
EAR
14.3 M - - $ 10.2 M usaUSA
Delcath Systems Delcath Systems
DCTH
73.4 M $ 10.8 4.05 % $ 387 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
42.4 M - - $ 475 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
584 K - -5.86 % $ 30.6 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
500 K - -0.97 % $ 54.4 M usaUSA
Electromed Electromed
ELMD
50 M $ 25.6 -0.43 % $ 216 M usaUSA
Avinger Avinger
AVGR
2 M - -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
198 M - - $ 3.31 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
18.4 M $ 3.47 4.52 % $ 130 M franceFrance
Aziyo Biologics Aziyo Biologics
AZYO
6.6 M - 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
229 K - 37.08 % $ 85.7 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
61 K $ 2.12 3.92 % $ 1.29 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
779 M $ 56.7 1.0 % $ 1.67 B usaUSA
Conformis Conformis
CFMS
23.2 M - - $ 16.4 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
940 M $ 61.0 1.5 % $ 3.33 B britainBritain
ClearPoint Neuro ClearPoint Neuro
CLPT
22.7 M $ 11.37 1.7 % $ 322 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
173 M - 0.15 % $ 844 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
26.5 M $ 0.61 0.36 % $ 38 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
168 M - -4.14 % $ 702 M usaUSA
Invacare Corporation Invacare Corporation
IVC
48.3 M - - $ 24.7 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
4.25 K - -1.98 % $ 98.3 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
19.2 M $ 1.03 - $ 17.4 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
28.7 M - 0.03 % $ 1.58 B israelIsrael
Dynatronics Corporation Dynatronics Corporation
DYNT
6.01 M - 14.99 % $ 929 K usaUSA
Misonix, Inc. Misonix, Inc.
MSON
43.7 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
1.99 M - - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
173 M $ 15.65 3.92 % $ 367 M usaUSA
Butterfly Network Butterfly Network
BFLY
48.8 M $ 5.4 12.97 % $ 1.14 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.2 M - - $ 955 M usaUSA
GBS GBS
GBS
1.25 M - -0.57 % $ 7.12 M usaUSA
Sintx Technologies Sintx Technologies
SINT
461 K $ 2.41 14.22 % $ 6.68 M usaUSA
Globus Medical Globus Medical
GMED
719 M $ 91.34 1.29 % $ 12.4 B usaUSA
TransMedics Group TransMedics Group
TMDX
363 M $ 100.01 -0.77 % $ 3.4 B usaUSA
NanoVibronix NanoVibronix
NAOV
153 K - - $ 1.08 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
750 M $ 36.8 0.38 % $ 1.14 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
500 M $ 84.03 -5.06 % $ 2.92 B usaUSA
Stryker Corporation Stryker Corporation
SYK
4.63 B $ 294.73 -6.47 % $ 113 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
4.73 B $ 83.98 0.57 % $ 49.1 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
167 M $ 19.41 -0.61 % $ 1.32 B usaUSA
LENSAR LENSAR
LNSR
14.1 M $ 5.61 7.27 % $ 67.1 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
67.1 M $ 1.35 5.47 % $ 54.9 M usaUSA
MiMedx Group MiMedx Group
MDXG
346 M $ 3.68 9.52 % $ 544 M usaUSA
Myomo Myomo
MYO
26.9 M $ 0.9 4.16 % $ 37.7 M usaUSA